De-escalation of Therapy in Inflammatory Bowel Disease

Medicine and Dentistry

• Immunomodulating Agent 100%
• Inflammatory Bowel Disease 100%
• Biological Product 50%
• Combination Therapy 50%
• Drug Dose Reduction 50%
• Side Effect 50%
• Health Care Cost 50%
• Therapeutic Management 50%
• Therapeutic Drug Monitoring 50%
• Drug Withdrawal 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Immunomodulating Agent 100%
• Side Effect 50%
• Biological Product 50%
• Combination Therapy 50%
• Therapeutic Drug Monitoring 50%